Cleanroom testing is often bought late and on price, and QA first meets the tester as a signature on a report. Before the order, hold evidence of tester training, calibrated instruments, method statements to ISO 14644-1 and ISO 14644-3, a sample report and agreed raw data practice, then list the tester as an approved supplier.
EU GMP Annex 15 (2015) says a formal release for the next qualification stage should be authorised, and that conditional approval to proceed can be given where there is a documented assessment of no significant impact on the next activity. That assessment is made item by item, against the tests that follow.
EU GMP Annex 15 (2015) accepts concurrent validation in exceptional circumstances, where there is a strong benefit-risk ratio for the patient. The decision must be justified, documented in the validation master plan and approved by authorised personnel. A project that is running late does not meet that test.
A protocol line that says 'as per design' leaves the tester to choose the document and the tolerance on test day. EU GMP Annex 15 (2015) says protocols should define the acceptance criteria. Write a number with its unit and tolerance, the method and room state, and the source document with its revision.
Analytical method transfer is the documented process that qualifies a receiving laboratory to use a procedure that originated elsewhere. Routes include comparative testing, co-validation, revalidation and a justified waiver. The WHO guideline on technology transfer says procedures should be implemented before process validation samples are tested, with acceptance criteria agreed before the protocol is executed.
The product quality review is the regular, documented review of each authorised medicinal product, normally annual in the 2013 text of EU GMP Chapter 1; the US rule is 21 CFR 211.180(e). One listed item is the qualification status of equipment and utilities such as HVAC and water, which engineering should keep current through the year.
A batch record followed to the letter does not tell a receiving site why each parameter sits where it does. The WHO guideline on technology transfer says the sending unit should make available all the necessary information and knowledge. Check for the development history, the justified control strategy, validated analytical procedures with stability data, and hold time and cleaning information.
21 CFR Part 11 and EU GMP Annex 11 overlap on validation, access control and audit trails but differ in emphasis: Part 11 on electronic signatures, Annex 11 on a risk-based system lifecycle. Fixing the destination market in the design basis means the URS and validation plan for BMS, EMS and SCADA are written once.
EU GMP grades map to different ISO 14644-1 classes at rest and in operation: Grade B is ISO 5 at rest and ISO 7 in operation. A URS line that quotes only one invites the wrong design. State both classes, the maximum number of people and the clean-up period.
Environmental monitoring and BMS data that support GMP decisions must meet ALCOA+. In practice that means individual logins, time-synchronized controllers, an audit trail users cannot disable, alarms acknowledged with name and comment, and tested backups, with GMP-critical parameters separated early onto a validated system.
URS, DQ, IQ, OQ and PQ are drawn as a sequence, but every test on the right of the V-model depends on a measurable requirement on the left. Writing the URS before concept design and starting the traceability matrix on day one turns late site changes into early drawing changes.
Under EU GMP Annex 1 (2022), the Contamination Control Strategy has to connect barriers, airflow, personnel and material flows, cleaning, utilities and monitoring. A useful test for any CCS: every line should point to a drawing, calculation or test, not to a procedure written after construction.